INTRODUCTION
In vitro fertilisation is part of the third generation of biotechnologies applied to reproduction (31) . Figure 1 shows the succession of these four generations, beginning with the historic turning point of artificial insemination. The actual technique of in vitro fertilisation is not new, as the first successful attempt to use such a technique in domestic mammals was made in 1954 by Dauzier and colleagues (5) , working on rabbits in France. However, further development was impossible until the in vitro culture of embryos was accomplished. Some years passed before the procedure was successfully applied to cattle, in the second half of the past decade (15) . This technique of biotechnology is still in the early stages and the first international exchanges of such embryos are now taking place, particularly between the countries of the European Community (EC). The four generations of reproduction biotechnologies (31) The veterinary scientific community has been aware for some five years of the difficult problem of evaluating the risks of transmitting diseases by embryo transfer. This community is very much aware of the interest of breeders, who are anxious to take advantage of these new tools of genetic material transfer, and is also greatly occupied with ensuring complete exclusion of all risk of transferring pathogens along with the embryos. Genes may be transferred, but not pathogens. The interaction between pathogens and spermatozoa or embryos collected after in vivo fertilisation (reviewed in 13) is now complicated by the interaction of pathogens and embryos fertilised in vitro because, as stated by Janssen and Cysouw (14) , such interaction may constitute an economic barrier to exchanges of genetic material, particularly international exchanges, unless this is properly controlled.
First generation
The author proposes to describe here the present state of knowledge on this subject, despite the novelty of this technology. There are various recent reviews of technical advances (7, 29, 31, 33) and even ethical aspects (25) but to date, and to the knowledge of the author, no examination has been made of the interaction between such embryos and pathogens. Figure 2 depicts the four indispensable stages of production before the embryos can be transferred effectively to recipient females by the natural (cervical) route. The essential technical features which could influence the type of health safeguards to be adopted are detailed below.
PRODUCTION OF EMBRYOS BY IN VITRO FERTILISATION

Oocyte maturation
The ovaries of cows (or heifers) contain many thousands of oocytes (female gametes) within the follicles constituted of ovarian somatic cells, at various stages of development. Only antral follicles are taken, for these can be examined to determine the completion of meiotic division. Meiotic division of these gametes commences during foetal development, but is blocked at a particular stage of the initial division of the gametes. Maturation, which takes place in vivo following peak liberation of gonadotropic hormones (follicle-stimulating hormone [FSH] and luteinising hormone [LH] ), consists of completion of nuclear division (up to the second metaphase stage) and the cytoplasmic maturation necessary in order to take charge of the paternal genome (29) . In addition to these two components, there are the peri-oocytic cells of the cumulus oophorus which are collected with the oocyte. For practical purposes, the gametes are extracted from antral follicles measuring approximately 2-6 mm and obtained from the living animal ("ovum pick-up" technique: 23) or from ovaries collected at the abattoir. In the latter case, the ovaries are placed in phosphate-buffered saline (PBS) and kept at 35°C during transport to the laboratory. Oocyte-cumulus complexes are separated from suitable ovarian follicles and placed in culture for in vitro maturation. In the laboratory where the present study was conducted (19) , the preparations are initially washed three times in tissue culture medium (TCM) 199 buffered with Hepes' medium and supplemented with 10% heat-inactivated serum from a cow in oestrus, and a combination of antibiotics (gentamicin, penicillinstreptomycin and nystatin). Then the oocytes are washed again with maturation medium (B2 Ménézo's medium), to which is subsequently added bovine foetal serum (15%), a combination of gonadotropic and oestrogenic hormones, and gentamicin solution. The oocytes are then cultured on monolayers of pre-ovulatory granulosa cells for 26 h under 5% C0 2 at 38.5°C.
Approximately ten to twelve oocytes are cultured from each ovary; this number is very much smaller (by many logarithms) than the potential total of gametes present in the ovary, thus adequately demonstrating the margin for progress still to be achieved. Only oocytes definitely surrounded by a compact and intact cumulus complex should be cultured, in order to have any chance of success. One of the most spectacular manifestations of effective maturation of such oocytes is the enormous expansion of the The various stages of producing in vifro-fertilised embryos (31) cumulus after 24-26 h (of the order of 90%). Unfortunately, this does not mean that the maturation occurring in vitro is identical with that occurring in vivo, as has been shown by Marquant-Le Guienne and colleagues (18) .
Capacitation of spermatozoa
This stage consists of conferring the ability to fertilise upon the male gametes, and involves a series of changes in the plasma membrane of the spermatozoon. In most
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cases, the spermatozoa are obtained from frozen semen. After the semen straw has thawed, the spermatozoa are allowed to "swim up" in modified Tyrode's medium (TALP) containing serum albumin (fraction 5) for one hour in order to concentrate the preparation of motile spermatozoa. After low-level centrifugation to collect the male gametes, the latter are again diluted with the final capacitation medium based on TALP plus a mixture of serum albumin (lipid-free fraction), gentamicin, hypotaurine solution, epinephrine, penicillamine and heparin. The beneficial effect of glycosaminoglycan on capacitation was first demonstrated by Parrish and colleagues (22) and has subsequently been confirmed many times since then. These compounds are present in abundance in the genital tract. The mixture of hypotaurine, epinephrine and penicillamine contributes to maintaining active motility of spermatozoa, vital to ensure penetration of the oocyte and fertilisation.
In vitro fertilisation
Oocytes which have undergone maturation for 26 h are washed in three successive baths of an in vitro fertilisation medium, based on TALP plus lipid-free bovine serum albumin, penicillin-streptomycin and pyruvate. The oocytes are placed in fertilisation tubes, to which is added a suspension of spermatozoa at a concentration of one million gametes per ml. The mature oocytes plus spermatozoa are then kept for 18 h at 38.5°C. On average, in this laboratory, 90% of the oocytes matured in vitro become fertilised, according to the presence of pronuclei or subsequent embryonic cleavage (19) .
Culture of embryos in vitro
At present, this stage is the most difficult to accomplish, because it has to support the in vitro development of embryos for six to seven days, a period when major metabolic changes take place, leading to initiation of a new living organism. The technological breakthrough which facilitated in vitro development arose from the work of Gandolfi and Moor (6) on sheep, in which the block to in vitro development of the embryo was abolished by introducing oviduct epithelial cells. Marquant-Le Guienne and colleagues (18) later demonstrated in cattle that these epithelial cells do not have to come from the oviduct, but could be replaced by others, such as uterine cells. The relative simplicity of preparing oviduct cells made them suitable for use by the dozen teams in the world which are producing such embryos. Research with well-identified cell-lines (e.g. 34) is particularly valuable from the health aspect, but the use of such cell-lines is still under study, and perhaps the best results will be achieved with a combination of many types of cells, each contributing to the provision of "factors" indispensable to the optimum development of the embryo under conditions of in vitro culture. In general, the rhythm of embryo division is approximately one cell cycle every 24 h, producing a 16-cell embryo four days after fertilisation, a morula by the fifth day and a young blastocyst by the sixth day. In fact, the cell divisions of embryo cultures in vitro are usually slower than those observed in vivo, and this also applies to embryos fertilised in vitro which have been transferred temporarily to an intermediate host (bovine embryos implanted into ewes, for example). The rate of development of male bovine embryos is greater than that of female embryos (20, 1) . This demonstrates the extraordinary complexity of the mechanisms involved; in vitro fertilisation can only attempt to mimic approximately the minimum requirements of these mechanisms.
In practice, in the laboratory where the present study was conducted, the young ova are washed 18 h after contact with spermatozoa in a solution of B2 Ménézo's medium containing foetal bovine serum, the corona is removed mechanically and the ova are transferred to the in vitro culture wells which contain oviduct cells. The embryos are washed, in general at intervals of 24 h with the same B2 Ménézo's medium plus antibiotics (gentamicin, nystatin, penicillin-streptomycin), 10% foetal bovine serum, then incubated at 38.5°C under 5% C0 2 .
Oviduct cells are invariably used as primary cultures in the form of monolayers or expiants. The lumen of oviducts collected at the abattoir at the same time as the ovaries is washed with Hanks' solution plus the antibiotic solution mentioned above. After centrifugation and removal of the supernatant fluid, the cells are distributed to wells suitable for monolayer formation. Non-adherent cell debris is removed by washing 24 h after the start of culture.
At present, under suitable conditions -bull spermatozoa with the characteristics of good fertility (19) and oocytes of good quality -it is possible to obtain an average of 30% of young blastocysts from large numbers of fertilised embryos, equivalent to 2.5-3 blastocysts per ovary collected at the abattoir, or 5 blastocysts per donor cow.
Transfer and pregnancy rate
The transfer of embryos produced in vitro requires a synchronisation as precise as possible between the uterine phase of the cycle of the recipient female and the state of development of the embryo. At present, the transfer of young blastocysts into females at the 6th day of the cycle (day 0 = day of standing oestrus) is preferred (12) , in order to make allowance for the theoretical difference between embryo and recipient, because of the slower development of the embryo in vitro. The transfer of one or two fresh embryos (24) , can result in a pregnancy rate of 50-60% (17) . The gestation rate for deep-frozen embryos fertilised in vitro is still irregular (approximately 20-40%), despite recent encouraging developments (16) , and this is approximately equivalent to one calf born from each ovary used for in vitro fertilisation.
TYPES OF RISK OF CONTAMINATION OF EMBRYOS PRODUCED BY IN VITRO FERTILISATION
The potential risks of contamination of such embryos are directly related to the chain of events during manipulation. Six types of risk associated with embryos collected after in vivo fertilisation (the conventional embryo transfer technique) are recognised (32) , ranging from the possible integration of a pathogen into the genome of the oocyte to external contamination of the embryo during storage. However, the latter is highly improbable under the conditions currently prevailing in France. In general, these risks involve: a) biological material taken from a donor animal b) environmental conditions during manipulation of embryos c) environmental conditions during storage or transport until transfer.
Clearly the probability of risk diminishes with each of the three stages, but evaluation and checking of the risks are still possible, as explained below.
Risks associated with biological material from the donor animal
Gamete cells
The first type of risk concerns potential contamination of the cell or even the genome of the gamete. To date, this has not been demonstrated to occur in mammals (28, 31) .
However, such a risk is common to all forms of reproduction, including natural service. In addition, a pathogen could penetrate the zona pellucida. There is no evidence that this occurs in ruminants, although most of the research has concentrated on embryos and on the zona pellucida of embryos (27) , and it has not yet been proved that the intimate structure of the zona pellucida of the unfertilised oocyte is identical with that of the embryo. This point is worth investigating and necessitates close attention to the medium in which oocytes are placed.
Somatic cells around the oocyte
The conditions of maturation in vitro require the presence of not only cumulus cells but also granulosa cells, which could become infected (see below). This is a real risk which has to be faced. The use of batches of frozen cells, as in this study, makes it possible to test for pathogens before use.
Cells of the genital tract
Similarly, the conditions of in vitro culture require the presence of somatic cells, which are generally shed from the oviduct. These cells could carry pathogens and must be tested. The replacement of such cells by well-defined and well-characterised celllines would reduce the surveillance needed at this stage. This line of research is important not only for improving the yields of the entire system, but also for improving the health status of the embryos.
Health risks associated with the environment in which in vitro-fertilised embryos are produced
Risks associated with the environment emphasise the great care which must be taken during manipulation in order to avert the introduction of potential contaminants into the biological material. What are the potential sources of such contamination ? The general environment of laboratory and storage premises is the first possibility. This problem can be overcome by installing the proper equipment: for example, a room can be devoted exclusively to the purpose and submitted to thorough and regular disinfection, and work conducted under a correctly-maintained laminar flux hood.
The supply of ovaries from the abattoir, which may be in large numbers, is another potential source of contamination. In this case, intelligent allocation of working space should arrange for manipulation of this biological material quite separately from areas devoted to subsequent stages.
A third possible source of contaminants is constituted by products of animal origin: serum from cows in oestrus, foetal bovine serum, serum albumin, etc. This problem is common to all cell-culture techniques and all conventional manipulations involved in embryo transfer. Therefore, this is not strictly an additional risk and can be overcome by competent management.
The entire production process is delicate and any defect in hygiene, not only in terms of pathogens, affects the entire production laboratory. Every laboratory experiences occasional contamination (most often, but not exclusively, by fungi) which inhibits embryo production, as this is extremely sensitive to such contamination. If put into practice, these observations strengthen the health guarantee of normally-developed embryos.
Risks associated with storage and transport
These risks are common to all exchanges of genetic material other than through live animals. Embryos produced by fertilisation in vitro are packed in straws provided with a plugging system, particularly by sealing, which is completely hermetic. Procedures developed recently for straws produced in France render them completely sterile before use. Therefore, it is almost impossible (except maliciously) to introduce any form of contamination into packed and stored embryos. Immediately before packing there is also the security of ten additional washings, as recommended for the conventional embryo transfer technique (27) , in order to provide a sterile packing medium for the embryos.
INTERACTION BETWEEN PATHOGENS AND EMBRYOS PRODUCED BY FERTILISATION IN VITRO
The newness of this technique, which is less than ten years old, no doubt explains the relative paucity of research on this interaction in comparison with research on conventional embryo transfer. If the principle, applied to the latter, that it is impossible to extrapolate from one agent to another or from one species to another (13) is adopted for the new technique, it becomes obvious that this problem is far from being solved. Experience gained for embryos collected after fertilisation in vivo is undoubtedly useful for in vitro products, if only in identifying the principal pathogens to be studied as a priority. This experience can also be utilised if it is proved that the behaviour of the zona pellucida of oocytes or embryos fertilised in vitro is analogous to that clearly established for bovine embryos collected seven days after in vivo fertilisation (4) . Unfortunately, the data currently available do not provide clear evidence regarding similarities or differences.
In the case of ovaries collected at the abattoir, Guérin and colleagues (8) showed that oocytes derived from the ovaries of twenty-nine cows likely to be representative of the normal population slaughtered in France at the time gave rise to in vitro-fertilised embryos without the presence of pathogens. The slaughtered females were tested serologically for brucellosis, enzootic bovine leukosis, infectious bovine rhinotracheitis (IBR/IPV) and bovine virus diarrhoea-mucosal disease (BVD-MD). Testing for BVD-MD virus was also performed on blood samples from these cows. One female was serologically positive for brucellosis at a titre which might indicate carriage of some bacteria; two were positive for enzootic bovine leukosis and five were positive for IBR/IPV virus. The pathogenic characteristics of this herpesvirus infection make it probable that the animals shed the virus. Twenty-one animals had previously been in contact with BVD-MD virus but there was no viraemia. All samples taken from immature oocytes, follicular fluid, oviduct cells, non-cleaved eggs and embryos were free from all pathogens. The authors concluded that, under routine conditions, embryos produced in this way could be transferred to recipients without health risks, but that it was nonetheless preferable to be aware of such risks when female donors of oocytes or somatic cells could be in the acute stage of clinical episodes.
The two sources of gametes, oocytes and spermatozoa, must be considered in this respect and certain studies have dealt with both of these.
Interaction between pathogens and oocytes
Bovine herpesvirus 1 (BHV1) was investigated by Guérin and colleagues (9) . These authors experimentally infected ten cows with the virus and performed ovariectomy 8-10 days after infection, immediately after peak viraemia. One hundred oocytes were taken, 80 of which matured in vitro and 27 of which commenced segmentation. BHV1 was recovered from the oocytes derived from five of the nine cows from which oocytes were obtained. In addition, the virus was demonstrated in the maturation medium for oocytes from seven cows (of nine), and in embryos from four of the nine cows from which embryos were obtained. Healthy oviduct cells, co-cultivated with embryos from experimentally-infected cows, yielded BHV1 in six of ten cases. However, all embryos collected from healthy cattle and cultured with oviduct cells from infected cows developed normally and did not present detectable contamination, despite being exposed to contamination on the day of tissue collection. In addition, the development of fertilised oocytes was reduced considerably when they were taken from virusinfected ovaries, in comparison with the healthy controls. This clearly shows that in vitro-fertilised embryos derived from animals in the acute stage of IBR/IPV could act as vectors of this pathogen, even though no transfer has been made, and the pathogenic risk to female recipients associated with such embryos remains unknown.
With regard to disease control, this study shows that maturation and culture media are entirely suitable for detecting the possible presence of this pathogen, because BHV1 virus has been recovered from maturation and culture media used for contaminated oocytes and embryos. Finally, the considerable reduction in the yield of the production process in the presence of BHV1 virus underlines the harmful effect of this virus (which consequently reduces the chance of transfer of such embryos) and the possible interaction by the virus in the process of fertilisation, although it is impossible at this stage to detect a direct effect on the fertilisation or development process, or an indirect effect due to changes in the surrounding medium.
The same team (10) examined the effect of in vitro contamination (no longer in vivo) of oocytes fertilised in vitro, confirming and extending the previous study. BHV1 became adsorbed onto the zona pellucida of oocytes or zygotes fertilised in vitro. The zona pellucida responded to this pathogen in the same way as in embryos collected seven days after fertilisation in vivo. In addition, detection of the virus in various maturation or culture fluids (Table I) confirmed the value of testing such media for the possible presence of this pathogen. Finally, BHV1 altered the ability of oocytes to become fertilised, particularly through a considerable increase in decondensation anomalies in the spermatozoa. This might mean that introduction of the pathogen into the oocytic cytoplasm may occur through fertilisation.
Similar investigations are in progress in the laboratory where the present study was conducted, using BVD-MD virus (Guérin and colleagues, personnal communication). The initial experiments on in vitro contamination of oocytes and embryos produced by in vitro fertilisation tend to show that this virus may adsorb onto the zona pellucida of oocytes, but not onto embryonic cells. Note that BVD-MD virus did not become adsorbed by the zona pellucida of embryos collected after in vivo fertilisation (26) . This may suggest identical behaviour by the zona pellucida of embryos fertilised in vitro and embryos collected in vivo, or alternatively a different structure of this membrane in oocytes confronted with this pathogen.
Interaction between pathogens and spermatozoa during in vitro fertilisation
In 1986, it was demonstrated that persistently-infected bulls with BVD-MD virus could excrete the virus in semen (2) . This could result in the infection of embryos fertilised in vitro. Bielanski and colleagues (3) attempted to determine whether the techniques currently used to produce embryos in vitro, such as those described above (separation by "swim up") could eliminate the presence of this virus. The conclusion was negative: this type of procedure was incapable by itself of eliminating the virus, and therefore it was essential to take every precaution to avoid the use of infected semen.
Similarly, Guérin and colleagues (11) obtained semen from a persistently-infected bull in which the presence of BVD-MD virus was confirmed. This virus was recovered from the spermatozoal fraction after "swim up", from both the sediment and the supernatant fluid, agreeing with later observations by Bielanski and colleagues (3). Virus was also isolated from the fertilisation medium, in the medium used for washing embryos cultured in vitro and on the embryos themselves (3). Research is in progress to determine whether the virus is located at the periphery or integrated into blastomeres. Moreover, the yield of developed, infected embryos was much poorer than the yield of control embryos (Table II) . These observations confirm that tests on the media used for the various stages of embryo production can be used to detect the possible presence of this pathogen. An interaction, under these conditions, between this virus and the processes of fertilisation and embryonic development (as established in the case of oocytes infected with BHV1 virus) raises once again the acuteness of the problem, i.e. can such pathogens penetrate the cytoplasm of the oocyte through fertilisation? This would be a biological discovery of primary importance, with repercussions on the understanding of the phenomena of early embryonic mortality, and on the manner of health surveillance of embryos fertilised in vitro or produced by cloning. 
STRATEGY FOR PRODUCING IN VITRO-FERTILISED EMBRYOS FREE FROM PATHOGENS: RECOMMENDATIONS AND REGULATIONS
Although there is nothing original in the principles of this strategy -aimed at providing complete protection for the breeder, farmer or country against the introduction of undesired pathogens while ensuring that this technology remains economically viable -certain specific features of this biotechnology of reproduction will, indeed, be quite novel. The five parts of this Appendix to the Code define the steps necessary to ensure that the embryos produced by in vitro fertilisation may be circulated freely without health risk, as reflected by the present state of knowledge detailed above.
The concept of the officially-approved team
The first wholly original point of this document is the concept of a team officially approved by the Veterinary Authorities. The purpose of this approval is to establish the responsibility of the operators engaged in embryo production. In principle, this is similar to the official approval of teams for conventional embryo transfer (30) , but the mode of application is different. These are two different types of approval. With regard to the new technique, the team is responsible for the entire production process for embryos fertilised in vitro and is approved specifically for this purpose. Three main conditions have to be fulfilled: -competence in the rules of hygiene and cleanliness, in addition to technical competence (a veterinarian has to be in charge of the team) -adequate and specific equipment and installations -supervision of the hygienic quality of the operation of the team.
The status of donor animals
The second essential point concerns the status of animals which provide oocytes. In the case of collection from a live animal (ovum pick-up), the conditions are identical to those required for conventional embryo transfer, because in such a situation the health status of the donor animal, the herd and also the region of origin of the herd may be easily identified. By contrast, in the case of ovaries collected at the abattoir, certain arrangements are needed to reduce as far as possible the probability of pathogens being present in follicles and oocytes. These conditions envisage the collection of ovaries from an officially-approved abattoir, which is hence under veterinary supervision for thorough inspection before and after slaughter. Any animal slaughtered as part of a disease eradication scheme disqualifies a batch of animals which might be used for oocyte collection. There has been much discussion of the need for identification of cows to ensure knowledge of the health status of the animal or the herd of origin. This point has not been upheld because such identification would be too expensive, would serve no genuinely useful purpose and would provide a false sense of security. One of the objectives of in vitro fertilisation is to produce embryos at a cost compatible with the price which the breeder is prepared to pay. This objective is not necessarily coupled with the production of animals of high value. Such products cannot support the additional cost and the procedure would be difficult to accomplish in practice when animals are slaughtered away from their home farm. Even in this computerised age, and in countries which can trace slaughtered animals, daily experience shows that it costs money and takes time to retrieve such information, and this is difficult to reconcile with the need to collect oocytes as quickly as possible.
Health supervision of the production process
The third point concerns health supervision of production operations, whether at the time of dispatch of specific batches of embryos fertilised in vitro, or within the general framework of health quality control of the officially-approved team by an official veterinary laboratory. Despite the limited amount of research conducted to date on the interaction between pathogens and in vitro-fertilised embryos, it has been clearly demonstrated that testing of the media in which oocytes and embryos are cultured is a highly efficient means of detecting the presence of a pathogen. Official approval of such teams provides the ethical basis for taking samples and identifying infected samples. In addition, and only if necessary, a local official veterinarian could enter the premises used by the team to take samples and inspect the packing and storage of embryos produced. With regard to semen, which could be involved in health problems (see above), the application of standards to semen produced by bulls at approved artificial insemination centres is sufficient to provide the necessary guarantee.
Regulations
At present, no regulations have been promulgated anywhere in the world for national or international exchanges. The Commission of the European Communities plans to modify EC Directive 89/552 of 25 September 1989 in order to incorporate specific conditions for embryos subjected to micromanipulation and fertilised in vitro. The terms of this modified Directive have been examined by an ad hoc committee of the Veterinary Scientific Committee, and are based essentially on the recommendations of the OIE International Animal Health Code.
Since the publication of the above text, European countries have set up a procedure for official approval of teams engaged in the production of in vitro-fertilised embryos. The author believes the number of such teams at the present time -in Europe, for example -to be two to three per country; there should therefore be no problem in ensuring supervision by official Veterinary Services.
In regard to international exchanges, many hundreds of embryos (from the United Kingdom and other European countries) have already been exchanged within the EC. Health certificates are based on OIE recommendations, including for the United Kingdom, which has added an article concerning bovine spongiform encephalopathy. To date, the system has operated efficiently and safely, with no incident having been reported.
The production of embryos fertilised in vitro is a third generation biotechnology of reproduction which is still undergoing development. It is certain to become one of the main technical features of animal breeding in the present decade.
Although this type of production is restricted, because of the difficulty of overcoming the problems of freezing such embryos, international exchanges are taking place, not only between European countries but also between continents. It is important for official Veterinary Authorities to be aware of this development and to permit such exchanges, which benefit the economics of animal breeding without jeopardising the national animal health status. The conditions presented here, which take account of the present state of knowledge, might seem to be too conservative in some ways, but they have the considerable value of reconciling health security with economic feasibility.
